SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   Form 10-QSB

                   Quarterly Report Under Section 13 or 15(d)
                     of the Securities Exchange Act of 1934

For Quarter Ended September 30, 1999           Commission File No.    0-15148

                         SCIENTIFIC NRG, INCORPORATED
            (Exact name of registrant as specified in its charter)

             Minnesota                                        41-1457271
(State or other jurisdiction of incorporation    (I.R.S. Employer Identification
or organization)                                                         Number)

4695 MacArthur Court, Suite 530, Newport Beach, CA                  92660
      (Address of principal executive offices)                    (Zip Code)

                                 (949) 833-2094
              (Registrant's telephone number, including area code)



     Indicate  by check mark  whether the  Registrant  (1) has filed all reports
required to be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of
1934 during the preceding 12 months (or for shorter  period that the  Registrant
was  required  to file such  reports),  and (2) has been  subject to such filing
requirements for the past 90 days.

                                                          Yes  X           No


                      APPLICABLE ONLY TO CORPORATE ISSUERS:


     As of November 12, 1999,  there were 32,023,897  shares of the Registrant's
no par value common stock issued and outstanding.


                                                [H:\SNRG\10-QSB\93099.qsb-2.wpd]
<PAGE>

                          SCIENTIFIC NRG, INCORPORATED
                                      INDEX

                                                                            Page
                                     PART I

Item 1.   Financial Statements

          Balance Sheet - September 30, 1999...................................1

          Statements of Operations - Three Months Ended
             September 30, 1999 and 1998.......................................2

          Statements of Stockholders Equity (Deficit) - Three Months Ended
             September 30, 1999................................................3

          Statements of Cash Flows - Three Months Ended
             September 30, 1999 and 1998.......................................4

          Notes to Financial Statements........................................5


Item 2.   Management's Discussion and Analysis of

          Financial Condition and Results of Operations........................8



                                     PART II

Item 1.   Legal Proceedings....................................................9

Item 2.   Changes In Securities................................................9

Item 3.   Defaults Upon Senior Securities......................................9

Item 4.   Submission of Matters to a Vote of Security Holders..................9

Item 5.   Other Information....................................................9

Item 6.   Exhibits and Reports on Form 8-K.....................................9

          Signatures..........................................................10

                                        I

                                                [H:\SNRG\10-QSB\93099.qsb-2.wpd]
<PAGE>

                          SCIENTIFIC NRG, INCORPORATED
                                  Balance Sheet
                      As of September 30, 1999 (Unaudited)

<TABLE>
<CAPTION>

ASSETS
<S>                                                                <C>

Current assets:
   Cash                                                            $     22,772
   Marketable securities                                                971,578
   Current portion of receivables from affiliates                       200,000
   Note receivable                                                       50,000
   Other current assets                                                  28,601

         Total current assets                                         1,272,951

Receivables from affiliates, net of allowance of $382,896
   net of current portion                                                73,779
Other receivables, net of allowance of $20,304                           20,304
Investments, at cost                                                    519,674
Investment in NuOasis Resorts, Inc.
   Convertible Preferred Stock, at cost                               8,000,000
Property and equipment, net                                              31,363


                                                                   $  9,918,071
</TABLE>

                       LIABILITIES AND STOCKHOLDERS EQUITY
<TABLE>
<S>                                                                <C>

Current liabilities:
   Accounts payable                                                $     27,419
   Accrued professional fees                                             37,153
   Other current liabilities                                             16,847

         Total current liabilities                                       81,419

Stockholders equity:
   Common stock, no par value; 40,000,000 shares authorized;
      32,023,897 shares issued and outstanding                       14,083,393
    Additional paid-in capital                                           27,025
    Unrealized loss on marketable securities                           (164,978)
    Accumulated deficit                                              (4,108,788)
         Total stockholders equity                                    9,836,652

                                                                   $  9,918,071
</TABLE>

              See accompanying notes to these financial statements

                                                [H:\SNRG\10-QSB\93099.qsb-2.wpd]
                                        1
<PAGE>

                          SCIENTIFIC NRG, INCORPORATED
                            Statements of Operations
                           For the Three Months Ended
                     September 30, 1999 and 1998 (Unaudited)


<TABLE>
<CAPTION>

                                        For the Three Months Ended
                                               September 30,
                                         1999                1998
                                      (Unaudited)         (Unaudited)
<S>                                   <C>                 <C>
 Net Sales                            $         -         $     70,652
 Cost of Sales                                  -               33,468
 Gross Profit                         $         -         $     37,184
Costs and expenses:
 General and administrative           $    86,341         $     63,280
     Totals                                86,341               63,280
Net income (loss)                         (86,341)        $    (26,096)
Net income (loss) per common share    $      (.00)        $       (.01)
Weighted average common
 shares outstanding                    32,023,897            5,586,163

</TABLE>




















              See accompanying notes to these financial statements

                                                [H:\SNRG\10-QSB\93099.qsb-2.wpd]
                                        2
<PAGE>

                          SCIENTIFIC NRG, INCORPORATED

                   STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIT)
                                   (Unaudited)




<TABLE>
<CAPTION>


                                                                         Unrealized
                                       Common Stock        Additional     Loss on                   Stockholders
                                 -----------------------    Paid-in      Marketable    Accumulated     Equity
                                  Shares       Amount       Capital      Securities      Deficit     (Deficit)
                                ----------   -----------   ----------   ------------   -----------  ------------

<S>                             <C>          <C>           <C>          <C>           <C>           <C>

Balances, June 30, 1999         31,723,897   $14,065,393   $   27,025            -    $(4,022,447)  $10,069,971

Common stock issued in
connection with services
rendered                           300,000        18,000            -            -              -        18,000

Unrealized loss on
marketable securities                    -             -            -     (164,978)             -      (164,978)

Net loss                                 -             -            -            -        (86,341)      (86,341)


  Balances, September 30, 1999  32,023,897   $14,083,393   $   27,025   $ (164,978)   $(4,108,788)  $ 9,836,652
</TABLE>





















                 See accompanying notes to financial statements

                                                [H:\SNRG\10-QSB\93099.qsb-2.wpd]
                                        3
<PAGE>

                          SCIENTIFIC NRG, INCORPORATED
                            Statements of Cash Flows
       For the Three Months Ended September 30, 1999 and 1998 (Unaudited)
<TABLE>
<CAPTION>

                                                                 Three Months
                                                              Ended September 30,
                                                              1999          1998
                                                          ------------   ------------
<S>                                                       <C>            <C>
Cash flows from operating activities:
   Net loss                                               $  (86,341)    $  (26,296)
   Adjustments to reconcile net loss to net cash
      Provided by operating activities:
      Depreciation                                                 -            465
      Common stock issued for services rendered               18,000         77,613
      Changes in operating assets and liabilities:
        (Increase) in inventories                                  -        (15,639)
        Decrease in other assets                                              7,649
        Increase (decrease) in accounts payable and
            accrued expenses                                   8,125        (23,602)
        Increase (decrease) in other  liabilities             81,329              -

   Net cash provided by (used in) operating activities        21,113         20,190


Net increase in cash                                          21,113         20,190

Cash at beginning of period                               $    1,659     $   14,367

Cash at end of period                                     $   22,772     $   34,557

Non-cash investing and financing activities:


   Common stock issued for services rendered              $   18,000     $   77,613
</TABLE>


              See accompanying notes to these financial statements

                                                [H:\SNRG\10-QSB\93099.qsb-2.wpd]
                                        4
<PAGE>

                          SCIENTIFIC NRG, INCORPORATED
                          NOTES TO FINANCIAL STATEMENTS
                               September 30, 1999
                                   (Unaudited)


NOTE 1.   ORGANIZATION AND HISTORY

Business and Organization

Scientific NRG, Incorporated,  dba Scientific Component Systems (the "Company"),
was  incorporated  in the state of Minnesota in 1983.  The Company  historically
designed,  manufactured and marketed custom energy efficient  lighting  products
utilizing  compact  fluorescent  lamp  technology  primarily  within  the United
States.  The  principal  products  were energy  efficient,  compact  fluorescent
downlight fixtures primarily for the downlight canister retrofit market.

On August 15,  1998,  the Companys  Board of Directors  approved the sale of the
Companys downlight business, which constitutes substantially all of the Companys
assets and operations.  On June 29, 1999, the Company  completed the sale of its
downlight  business which included  substantially all of the Companys assets and
operations.

Effective  June 30, 1999, the Company  consummated  an asset purchase  agreement
with NuVen Capital L.P. (NuVen), which resulted in the Company acquiring certain
assets of NuVen, in exchange for 22,344,652  shares of the Companys common stock
valued at $10,090,793,  based the estimated fair value of the underlying  assets
acquired.  No liabilities were assumed in this transaction.  The assets obtained
by the Company  consisted  of Series D  Convertible  Preferred  Stock of NuOasis
Resorts,  Inc.,  totaling  $8,000,000;   certain  receivables,   primarily  from
affiliates,  with a net carrying  value of $403,200;  marketable  securities  in
affiliates totaling $1,136,556;  and other non-current assets totaling $551,037.
As a result of this transaction, NuVen obtained approximately 70% control of the
Company. The assets acquired were accounted for at historical bases similar to a
recapitalization.

NOTE 2.   SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Going Concern

     At September 30, 1999, the Companys operation consisted of managing certain
investments  and  seeking  business  opportunities.  The  Companys  plan  is  to
liquidate or exchange its interests to acquire  interests in other  ventures and
new opportunities. Management believes that its working capital is sufficient to
meet its working capital requirements for a period of 12 months from the balance
sheet date.

Use of Estimates

The  preparation  of the  financial  statements  in  conformity  with  generally
accepted  accounting  principles  requires  management  to  make  estimates  and
assumptions  that affect the  reported  amounts of assets and  liabilities,  and
disclosure of contingent liabilities at the date of the financial statements and
the  reported  amounts of revenues  and expenses  during the  reporting  period.
Actual results could differ from those estimates.

Property and Equipment

The values reflected in its Annual Report on Form 10 KSB for the Companys fiscal
year ended June 30, 1999, are carried forward here at $31,363.  Depreciation for
the current year will be taken into consideration at year end.


                                                [H:\SNRG\10-QSB\93099.qsb-2.wpd]
                                        5

<PAGE>

                          SCIENTIFIC NRG, INCORPORATED
                          NOTES TO FINANCIAL STATEMENTS
                               September 30, 1999
                                   (Unaudited)


NOTE 2.   SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

Earnings (Loss) Per Common Share

Net income  (loss) per common share is  calculated by dividing net income (loss)
by the weighted average number of shares outstanding  during the period.  Common
stock equivalents were not considered in the loss per share  calculations as the
effect would have been anti dilutive.

Issuance of Common Stock for Services

On July 14, 1999, the Company issued 300,000 shares of common stock for services
to be rendered in connection  with a retainer  agreement which commenced on July
1, 1999 and expiring on June 30, 2000. Such shares were registered by management
of the Company with the Securities and Exchange Commission pursuant to Form S-8.

NOTE 3.   MARKETABLE SECURITIES

In connection with the asset purchase agreement with NuVen, the Company obtained
shares  of common  stock in  affiliated  companies  of  NuVen.  Each  investment
represents  less than 10% of the  outstanding  common  stock of the investee and
each security is nationally  quoted on the OTC:  Bulletin  Board of the National
Association of Securities  Dealers. As such, each investment is accounted for in
accordance with the provisions of SFAS No. 115.

Management has classified these investments as  available-for-sale  based on its
intent to liquidate,  or exchange these equity securities for other interests or
operating  businesses.  In accordance with the provisions of SFAS No. 115, these
equity  securities  are presented in the  accompanying  balance sheet as current
assets at their estimated fair values. Management has determined the fair market
value of these  investments  in accordance  with the provisions of SFAS No. 115.
The fair market value at September 30, 1999, of the  Marketable  Securities  was
$971,578 and the Companys  carrying value was $1,136,556.  The fair market value
at November 10, 1999,  of these  Securities  was  $1,074,070.  In the opinion of
management,  the difference of $164,978 at September 30, 1999, is not considered
material when compared to Total Stockholders Equity of $10,001,630.

NOTE 4.   RECEIVABLES FROM AFFILIATES

Receivables From Affiliates

Receivables from affiliates represent non-interest bearing amounts in the amount
of $656,675.  Of this amount,  $631,675 is due from certain affiliated companies
and approximately $25,000 is due from an officer of the Company. As of September
30, 1999, management had deemed the collectable portion of the receivables to be
approximately  $273,779, as such, the accompanying  financial statements include
an allowance for doubtful accounts.

                                                [H:\SNRG\10-QSB\93099.qsb-2.wpd]
                                        6
<PAGE>

                          SCIENTIFIC NRG, INCORPORATED
                          NOTES TO FINANCIAL STATEMENTS
                               September 30, 1999
                                   (Unaudited)

NOTE 5.   INVESTMENTS AT COST

In connection with the asset purchase  agreement,  the Company  acquired certain
investments  in  affiliated  companies.  Included  in  these  investments  is an
investment in the Yes license at a cost to NuVen of $389,481.

In accordance with generally accepted accounting principles,  the acquisition of
the Yes  license was  recorded at  predecessor  basis.  The Company  also has an
interest in 3.5 million  shares of common  stock of Yes valued at  approximately
$0.03 per share for a total  investment  at fair market  value of  $91,382.  The
Company  intends  to  carry  this  investment  at  cost  due to  the  relatively
immaterial amount of the investment.

Also included in investments at cost are investments in the common stock of Hart
and Diversified. The Company acquired 750,000 and 474,085 shares of common stock
of Hart and Diversified,  respectively.  Currently, there is no market for these
shares and thus, the fair market price per share is not readily determinable. As
such, these investments are recorded in the accompanying financial statements as
of September  30, 1999 at  predecessor  basis of $7,500 and $31,311 for Hart and
Diversified, respectively.


NOTE 6.   INVESTMENT IN NuOASIS RESORTS, INC.

In connection with the asset purchase agreement with NuVen, the Company acquired
19,200,000  shares of NuOasis Resort,  Inc., Series D Preferred on June 30, 1999
with a  carrying  value of  $8,000,000.  The  Company  obtained  an  independent
appraisal  of the Series D  Preferred  at a fair market  value of  approximately
$10.9  million.  Since the  Company is  required  to record the asset  using the
predecessors basis, the Company recorded the investment at $8,000,000.

In  accordance  with  generally  accepted  accounting  principles,  the Series D
Preferred  is accounted  for under the cost  method,  since the Company does not
share in the earnings and losses of NuOasis Resorts,  Inc., since  participation
in  earnings  and  losses  is based on the  shares of  common  stock  held by an
investor without  recognition of securities of the investee which are designated
as common stock equivalents.




                                                [H:\SNRG\10-QSB\93099.qsb-2.wpd]
                                        7
<PAGE>

ITEM 2.  MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
         AND RESULTS OF OPERATIONS

         Going Concern

     The Company has experienced recurring net losses and management's intent is
     to continue searching for additional  business  opportunities.  The Company
     intends to utilize its asset base as a source of  operating  capital  while
     continuing  to  operate  with  minimal  overhead  and  key   administrative
     functions  provided by consultants  who are  compensated in the form of the
     Company's common stock.  Accordingly, the accompanying financial statements
     have been  presented  under the  assumption  the Company will continue as a
     going concern.


         Results of Operations

     Quarter Ended  September  30, 1999 Compared to Quarter Ended  September 30,
     1998

     There were no operations during the quarter ended September 30, 1999 and as
     such,  there  were no  revenues  or cost of  revenues  recorded  during the
     current  quarter.  In the quarter ended September 30, 1998, the Company was
     operating  at minimum  levels and the  decision  was made  during this 1999
     period by the Board of Directors to seek other opportunities.

     General and  administrative  expenses  was  $68,341 in the current  quarter
     compared  to  $63,280 in the  comparable  period  last year.  The change is
     attributable to continued services provided by professional consultants and
     other advisors.

         Liquidity and Capital Resources

     As of September 30, 1999, the Company had working  capital of $1,356,510 an
     increase of $12,988 from June 30, 1998.

     The  Company  had cash  balances  of  approximately  $22,772 and $34,557 at
     September 30, 1999 and 1998, respectively. The limited cash balance in 1999
     is a direct result of the Company having no operations during the quarter.

     The Companys plan is to keep  searching for  additional  sources of capital
     and new operating  opportunities.  In the interim, the Company will utilize
     its asset base as a source of funds to sustain operations.

                                                [H:\SNRG\10-QSB\93099.qsb-2.wpd]
                                        8
<PAGE>

PART II:  OTHER INFORMATION

Item 1.   Legal Proceedings

               None

Item 2.   Changes In Securities

               None

Item 3    Defaults Upon Senior Securities

               None

Item 4,   Submission Of Matters To A Vote Of Security Holders

               None

Item 5.   Other Information

               None

Item 6.   Exhibits And Reports On Form 8-K

     (a)    Exhibits - None

     (b) On July 28, 1999,  the Company  filed a Form 8-K  reporting a change in
the Registrants Certified Accountants from Corbin & Wertz to McKennon, Wilson &
Morgan,  LLP,  effective  July 21, 1999. On August 23, 1999, the Company filed a
Form 8-K/A  amending the July 28, 1999,  report to provide  further  particulars
regarding the change in Certified Accountants.

                                                [H:\SNRG\10-QSB\93099.qsb-2.wpd]
                                        9
<PAGE>

                                   SIGNATURES



     Pursuant  to the  requirements  of  Section  13 or 15(d) of the  Securities
     Exchange  Act of 1934,  the  Registrant  has duly  caused this report to be
     signed on its behalf by the undersigned, thereunto duly authorized.

                                       SCIENTIFIC NRG, INCORPORATED
                                       (Registrant)



Date:     November 15, 1999            By:/s/   Fred G. Luke
                                       Fred G. Luke,
                                       President and Principal Accounting Person


                                       10